Internacionales Noticias Internacionales Tras Su Reunión Con Rubio, Netanyahu Negociará Con Hamas La Continuidad De La Tregua En Gaza

How AI helps detect lung cancer sooner, improving survival rates

New artificial intelligence technology is helping diagnose the U.S.’s most deadly cancer sooner, greatly improving the chances of patients’ survival. Read More

A Look at the Past, Present, and Future of Small Cell Lung Cancer Treatment

Future SCLC treatment may involve combining T-cell engagers with immune checkpoint inhibitors to enhance patient outcomes. The landscape of small cell lung cancer (SCLC) is undergoing a significant ... Read More

Imdelltra May Improve Survival in Small Cell Lung Cancer

Imdelltra significantly improves survival in SCLC patients post-platinum chemotherapy, meeting primary endpoints in the DeLLphi-304 trial. As a BiTE immunotherapy, Imdelltra enhances T cell-cancer ... Read More

Imdelltra Shows Survival Benefit in Small Cell Lung Cancer

Imdelltra significantly improved progression-free and overall survival compared to chemotherapy in small cell lung cancer patients, with a median overall survival of 13.6 months versus 8.3 months. The ... Read More

Tarlatamab Improves Overall Survival in Small Cell Lung Cancer

Results showed tarlatamab demonstrated statistically significant and clinically meaningful improvement in overall survival vs standard of care therapy. Topline data were announced from a phase 3 trial ... Read More

FDA Grants Full Approval To Amgen's Imdelltra In Extensive Stage Small Cell Lung Cancer

Global Confirmatory Phase 3 DeLLphi-304 Trial Showed IMDELLTRA Reduced Risk of Death by 40% Compared to Chemotherapy Underscores IMDELLTRA as a Recognized Standard ... Read More

Lung Cancer Survival Has Improved in US, American Lung Association Report Shows

In just the past 8 years since we launched this report, the 5-year survival rate has gone from 18% to nearly 30%,” said Harold Wimmer, President and CEO of the American Lung Association. In the US, ... Read More

Ivonescimab Plus Chemotherapy Demonstrates Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival in Patients with EGFR-Mutant Non-Small ...

MIAMI--(BUSINESS WIRE)--Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced topline results from the Phase III clinical trial, HARMONi, the first global Phase ... Read More

Defying the Odds With Small Cell Lung Cancer: Montessa Lee’s 19-Year Journey Is a Beacon of Hope

Diagnosed with small-cell lung cancer at 28, Montessa Lee has defied the odds for nearly 20 years, surviving a disease with a historically low survival rate of just 5–10% according to the National ... Read More

Characteristics and Associated Survival of Patients Diagnosed With Non–Small Cell Lung Cancer in a Designated Lung Cancer Program in Western Kenya

Two hundred forty-nine patients diagnosed with NSCLC were included with a median age at diagnosis of 61 (IQR, 52-70) years. Most patients were married (n = 177; 71%) and nonsmokers (n = 177; 71%) with ... Read More